Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jennifer Wilson

Nurse Practitioner, Family Honolulu, HI Nurse Practitioner

NPI 1497117162 CMS profile 11010775

1401 S Beretania St Ste 400, Honolulu, HI 96814

Open in the dashboard

General payments

$4,212

80 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Wilson of Honolulu, HI is reported in the CMS Open Payments database as having received $4,212 across 80 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,131 15
2024 General $1,809 27
2023 General $449 12
2022 General $405 5
2021 General $418 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Wilson
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Jennifer Wilson were reported at $1,131. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Jennifer Wilson Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $418 $124 $35–$379 $132
2022 $405 $141 $44–$430 $149
2023 $449 $154 $49–$476 $160
2024 $1,809 $165 $51–$504 $164
2025 $1,131 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $2,456 58 payments
  2. BIOTRONIK NRO, Inc. $647 7 payments
  3. Abbott Laboratories $300 2 payments
  4. Nevro Corp. $295 6 payments
  5. Medtronic, Inc. $184 2 payments
  6. SI-BONE, Inc. $155 1 payment
  7. Pacira Pharmaceuticals Incorporated $116 2 payments
  8. AbbVie, Inc. $32 1 payment
  9. Stryker Corporation $27 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,212 80 payments
Products named General payments · program years 2021–2025
  1. General - Pain Management $720 10 payments
  2. WaveWriter Alpha Prime 16 WaveWriter Alpha_NMD $385 10 payments
  3. Prospera $339 4 payments
  4. PROCLAIM $300 2 payments
  5. WAVEWRITER ALPHA $292 9 payments
  6. Omnia $276 5 payments
  7. INTELLIS ADAPTIVESTIM $184 2 payments
  8. Spectra WaveWriter $173 1 payment
  9. WaveWriter Alpha Prime 16 WaveWriter Alpha NMD $164 1 payment
  10. BIOTRONIK $161 2 payments
  11. Other $488 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

481

Median for Nurse Practitioner: 389

Drug cost

$24,589

Median for Nurse Practitioner: $21,885

Branded share of claims

41.8%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycontin Oxycodone Hcl Brand 29 $11,584
Pregabalin Generic 101 $4,229
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 102 $2,743
Oxycodone Hcl Generic 99 $2,389
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 59 $2,114
Celecoxib Generic 13 $489
Tizanidine Hcl Generic 23 $378
Gabapentin Generic 13 $195
Acetaminophen-Codeine Acetaminophen With Codeine Brand 11 $162
Tramadol Hcl Generic 19 $158

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Records

80 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Hawaii

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record